These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 15168802

  • 1. Chemokine mRNA levels in mononucleated cells of HIV-infected patients before and after initiation of PI- versus NNRTI-containing HAART.
    Wasmuth JC, Nischalke HD, Jütte A, Fätkenheuer G, Salzberger B, Sauerbruch T, Spengler U, Rockstroh JK, Dumoulin FL.
    Antiviral Res; 2004 Mar; 61(3):207-12. PubMed ID: 15168802
    [Abstract] [Full Text] [Related]

  • 2. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
    Nischalke HD, Nattermann J, Fischer HP, Sauerbruch T, Spengler U, Dumoulin FL.
    Mediators Inflamm; 2004 Dec; 13(5-6):357-9. PubMed ID: 15770052
    [Abstract] [Full Text] [Related]

  • 3. Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, beta-chemokines and IL-16 secretion in HIV-1 infection.
    Burton CT, Hardy GA, Sullivan AK, Nelson MR, Gazzard B, Gotch FM, Imami N.
    Clin Exp Immunol; 2002 Nov; 130(2):286-92. PubMed ID: 12390317
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.
    Heggelund L, Damås JK, Yndestad A, Holm AM, Mūller F, Lien E, Espevik T, Aukrust P, Frøland SS.
    Clin Exp Immunol; 2004 Oct; 138(1):116-21. PubMed ID: 15373913
    [Abstract] [Full Text] [Related]

  • 5. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
    Vicenzi E, Alfano M, Ghezzi S, Gatti A, Veglia F, Lazzarin A, Sozzani S, Mantovani A, Poli G.
    J Leukoc Biol; 2000 Sep; 68(3):405-12. PubMed ID: 10985258
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sustained suppression of plasma HIV RNA is associated with an increase in the production of mitogen-induced MIP-1alpha and MIP-1beta.
    Kumar D, Parato K, Kumar A, Sun E, Cameron DW, Angel JB.
    AIDS Res Hum Retroviruses; 1999 Aug 10; 15(12):1073-7. PubMed ID: 10461827
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 counts.
    Waters L, Stebbing J, Jones R, Michailidis C, Sawleshwarkar S, Mandalia S, Bower M, Nelson M, Gazzard B.
    J Antimicrob Chemother; 2004 Aug 10; 54(2):503-7. PubMed ID: 15201230
    [Abstract] [Full Text] [Related]

  • 13. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
    Staszewski S, Morales-Ramirez J, Tashima KT, Rachlis A, Skiest D, Stanford J, Stryker R, Johnson P, Labriola DF, Farina D, Manion DJ, Ruiz NM.
    N Engl J Med; 1999 Dec 16; 341(25):1865-73. PubMed ID: 10601505
    [Abstract] [Full Text] [Related]

  • 14. CC and C chemokine expression in pulmonary sarcoidosis.
    Petrek M, Kolek V, Szotkowská J, du Bois RM.
    Eur Respir J; 2002 Nov 16; 20(5):1206-12. PubMed ID: 12449175
    [Abstract] [Full Text] [Related]

  • 15. Lack of good correlation of serum CC-chemokine levels with human immunodeficiency virus-1 disease stage and response to treatment.
    Ye P, Kazanjian P, Kunkel SL, Kirschner DE.
    J Lab Clin Med; 2004 May 16; 143(5):310-9. PubMed ID: 15122175
    [Abstract] [Full Text] [Related]

  • 16. Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy.
    Blanco J, Cabrera C, Jou A, Ruiz L, Clotet B, Esté JA.
    AIDS; 1999 Apr 01; 13(5):547-55. PubMed ID: 10203379
    [Abstract] [Full Text] [Related]

  • 17. Detection and localization of chemokine gene expression in autoimmune thyroid disease.
    Kemp EH, Metcalfe RA, Smith KA, Woodroofe MN, Watson PF, Weetman AP.
    Clin Endocrinol (Oxf); 2003 Aug 01; 59(2):207-13. PubMed ID: 12864798
    [Abstract] [Full Text] [Related]

  • 18. Fibroblast expression of C-C chemokines in response to orthopaedic biomaterial particle challenge in vitro.
    Yaszay B, Trindade MC, Lind M, Goodman SB, Smith RL.
    J Orthop Res; 2001 Sep 01; 19(5):970-6. PubMed ID: 11562149
    [Abstract] [Full Text] [Related]

  • 19. Highly active antiretroviral therapy normalizes the potential for MIP-1alpha production in HIV infection.
    Carter LM, Peters BS, Ellis BA, Wolstencroft RA.
    J Infect; 2000 Nov 01; 41(3):252-5. PubMed ID: 11120614
    [Abstract] [Full Text] [Related]

  • 20. The limited infectability by R5 HIV of CD34(+) cells from thymus, cord, and peripheral blood and bone marrow is explained by their ability to produce beta-chemokines.
    Majka M, Rozmyslowicz T, Ratajczak J, Dobrowsky A, Pietrzkowski Z, Gaulton GN, Janowska-Wieczorek A, Ratajczak MZ.
    Exp Hematol; 2000 Dec 01; 28(12):1334-42. PubMed ID: 11146155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.